lifestyle.ukuncut.org.uk

Author: uniQure Inc.

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease

April 30, 2026
uniQure to Announce First Quarter 2026 Financial Results

April 28, 2026
uniQure Announces 2025 Financial Results and Provides Recent Company Updates

March 2, 2026
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease

March 2, 2026
uniQure to Announce 2025 Financial Results

February 23, 2026
uniQure Announces Updated Preliminary AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

February 10, 2026